TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
XNCR

Xencor Inc

Healthcare · Biotechnology

25.20$ +0.5% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement XNCR
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
+191.6% +215.3% -59.2% +13.7% +285.9% -21.7% +124.2% -40.2% +2.3% -34.4% +13.7%
+84.4% +51.9% +38.4% +35.8% +21.6% +43.2% -95.6% +17.5% +2,782.1% -10.2% -95.4%
+215.3% -59.2% +13.7% -6.1% +221.9% +124.2% -40.2% -151.8%
+84.4% +51.9% +38.4% +35.8% +21.6% +43.2% +13.4% +3.7% +27.1% -10.2% +5.2%
+60.3% +9.6% +33.5% +28.4% +8.1% +22.2% +30.8% +22.3% +12.4% -6.2% +27.1%
+77.5% +41.0% +37.4% +34.4% -79.8% +721.4% +16.0% +6.8% +24.3% -80.1% +377.9%
-337.6% -655.5% -288.4%
+44.4% +61.5% -38.1% +23.1% +110,281.3% -100.0% +390.8% -83.2% +493.2% -12.9%
-300.6% -355.0% -166.0%
-146.7% -96.5% -1,957.1% +763.4% -72.2% +54.9%
-307.1% -336.4% -166.8%
-314.7% -491.8% -243.7%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?